A variety of organisms, such as bacteria, fungi, and plants, produce secondary metabolites, also known as natural products. Natural products have been a prolific source and an inspiration for numerous medical agents with widely divergent chemical structures and biological activities, including antimicrobial, immunosuppressive, anticancer, and anti-inflammatory activities, many of which have been developed as treatments and have potential therapeutic applications for human diseases. Aside from natural products, the recent development of recombinant DNA technology has sparked the development of a wide array of biopharmaceutical products, such as recombinant proteins, offering significant advances in treating a broad spectrum of medical illnesses and conditions. Herein, we will introduce the structures and diverse biological activities of natural products and recombinant proteins that have been exploited as valuable molecules in medicine, agriculture and insect control. In addition, we will explore past and ongoing efforts along with achievements in the development of robust and promising microorganisms as cell factories to produce biologically active molecules. Furthermore, we will review multi-disciplinary and comprehensive engineering approaches directed at improving yields of microbial production of natural products and proteins and generating novel molecules. Throughout this article, we will suggest ways in which microbial-derived biologically active molecular entities and their analogs could continue to inspire the development of new therapeutic agents in academia and industry.

Hydrogen storage properties of mutiwalled carbon nanotubes (MWCNTs) with Ni nanoparticles were investigated. The metal nanoparticles were dispersed on MWCNTs surfaces using an incipient wetness impregnation procedure. Ni catalysts have been known to effectively dissociate hydrogen molecules in gas phase, providing atomic hydrogen possible to form chemical bonding with the surfaces of MWCNTs. Hydrogen desorption spectra of MWCNTs with 6 wt % of Ni nanoparticles showed that approximately 2.8 wt % hydrogen was released in the range of 340-520 K. In Kissinger's plot to evaluate the nature of interaction between hydrogen and MWCNTs with Ni nanoparticles, the hydrogen desorption activation energy was measured to be as high as approximately 31 kJ/mol.H(2), which is much higher than the estimates of pristine SWNTs. C-H(n)() stretching vibrations after hydrogenation in FTIR further supported that hydrogen molecules were dissociated when bound to the surfaces of MWCNTs. During cyclic hydrogen absorption/desorption, there was observed no significant decay in hydrogen desorption amount. The hydrogen chemisorption process facilitated by Ni nanopaticles could be suggested as an effective reversible hydrogen storage method.

No abstract

A carbon-free Li(4)Ti(5)O(12) electrode has shown excellent electrochemical performance without any effort to enhance the electrical conductivity. Partial reduction of Ti(4+) and a metallic Li(7)Ti(5)O(12) phase are suggested to be possible origins of the exceptional behavior.

Morphology-controlled MoS2 nanosheets were successfully synthesized with the aid of graphene/acid coexistence by a one-pot hydrothermal method. The ultrathin MoS2 nanosheets were self-assembled into a cockscomb-like structure with an exposed (100) facet on graphene sheets, which is in strong contrast to large aggregate MoS2 plates grown freely on graphene sheets without acetic acid. The ultrathin MoS2 nanosheets displayed excellent rate performance for Li storage (709 mAh·g(-1) capacity at 8320 mA·g(-1) discharging rate) and superior charge/discharge cyclability.

Campesterol, a plant sterol in nature, is known to have cholesterol lowering and anticarcinogenic effects. Since angiogenesis is essential for cancer, it was surmised that an antiangiogenic effect may be involved in the anticancer action of this compound. This study investigated the effect of campesterol on basic fibroblast growth factor (bFGF)-induced angiogenesis in vitro in human umbilical vein endothelial cells (HUVECs) and an in vivo chorioallantoic membrane (CAM) model. Campesterol isolated from an ethylacetate fraction of Chrysanthemum coronarium L. showed a weak cytotoxicity in non-proliferating HUVECs. Within the non-cytotoxic concentration range, campesterol significantly inhibited the bFGF-induced proliferation and tube formation of HUVECs in a concentration-dependent manner, while it did not affect the motility of HUVECs. Furthermore, campesterol effectively disrupted the bFGF-induced neovascularization in chick chorioallantoic membrane (CAM) in vivo. Taken together, these results support a potential antiangiogenic action of campesterol via an inhibition of endothelial cell proliferation and capillary differentiation.

No abstract

A 2H-MoS2 (H=hexagonal) ultrathin nanomesh with high defect generation and large porosity is demonstrated to improving electrochemical performance, including in lithium-ion batteries (LIBs) and the hydrogen evolution reaction (HER), with the aid of a 3D reduced graphene oxide (RGO) scaffold as fast electron and ion channels. The 3D defect-rich MoS2 nanomesh/RGO foam (Dr-MoS2 Nm/RGO) can be easily obtained through a one-pot cobalt acetate/graphene oxide (GO) co-assisted hydrothermal reaction, in which GO, cobalt and acetate ions are co-morphology-controlling agents and defect inducers. As an anode material for LIBs, Dr-MoS2 Nm/RGO has only a 9% capacity decay at a 10 C discharge rate versus 0.2 C with stable cyclability at the optimized composition (5 wt% RGO to MoS2 and 2 mol% Co to Mo), and significantly achieves 810 mA h g(-1) at a high current density of 9.46 A g(-1) over at least 150 cycles. Moreover, Dr-MoS2 Nm/RGO exhibits superior activity for the HER with an overpotential as low as 80 mV and a Tafel slope of about 36 mV per decade. In contrast to the MoS2 nanosheet/RGO (MoS2 Ns/RGO), which is synthesized in the absence of cobalt ions, Dr-MoS2 Nm/RGO provides high interconnectivity for efficient lithium-ion transport, and rich defects as electrochemically active sites. DFT is used to prove the existence of rich defects due to anion replacement to become a Co-Mo-S atomic structure, releasing inert basal planes to active sites.